<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04519801</url>
  </required_header>
  <id_info>
    <org_study_id>C.2020.053</org_study_id>
    <nct_id>NCT04519801</nct_id>
  </id_info>
  <brief_title>BFR Therapy for Post-Op Rehab of ACL Reconstruction With Quadriceps Tendon Autograft</brief_title>
  <official_title>Blood Flow Restriction Therapy for the Post-Operative Rehabilitation of Anterior Cruciate Ligament Reconstruction With Quadriceps Tendon Autograft: A Randomized, Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Brooke Army Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>American Orthopaedic Society for Sports Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Brooke Army Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The overall objective of the proposed research is to conduct a prospective, randomized&#xD;
      controlled trial to investigate whether the addition of BFR therapy to standard&#xD;
      post-operative rehabilitation regimen significantly improves clinical outcomes following&#xD;
      anterior cruciate ligament reconstruction (ACLR) standardized with respect to both surgical&#xD;
      technique and graft selection. Patients indicated for ACLR will be screened and offered&#xD;
      enrollment into this prospective, randomized controlled trial. MRI of bilateral thighs will&#xD;
      be performed within 7 days of ACLR. Patients will be randomized to either REHAB or REHAB +&#xD;
      BFR (study intervention) using a block randomization scheme. Patients will undergo repeat MRI&#xD;
      of bilateral thighs at 16 weeks and 52 weeks post-operatively (primary outcome measure.)&#xD;
      Patient reported outcome (PRO) instruments will be administered pre-operatively to establish&#xD;
      pre-operative debility related to ACL injury and subsequently after ACLR at 24 weeks, 36&#xD;
      weeks, and 52 weeks post-operative (secondary outcome measures).&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The overall objective of the proposed research is to conduct a prospective, randomized&#xD;
      controlled trial to investigate whether the addition of BFR therapy to standard&#xD;
      post-operative rehabilitation regimen significantly improves clinical outcomes following ACLR&#xD;
      standardized with respect to both surgical technique and graft selection. The investigator's&#xD;
      central hypothesis is that the addition of BFR therapy has the potential to accelerate&#xD;
      surgical recovery, expedite return-to-duty, and maximize medical readiness following ACLR. In&#xD;
      the proposed trial validated patient reported outcome measures will be used to assess for&#xD;
      functional clinical improvement, while quadriceps musculature cross sectional area (CSA) as&#xD;
      measured on MRI will be used to quantify the effect of therapy on quadriceps strength. The&#xD;
      rationale for using this modality is based upon the fact that the measurement of quadriceps&#xD;
      CSA and muscle volume as surrogates for overall quadriceps function is well described, and a&#xD;
      number of studies have convincingly demonstrated positive correlations between these&#xD;
      parameters and quadriceps strength4, 17. However, in spite of these reports, the acceptance&#xD;
      acknowledging MRI as a surrogate for quadriceps strength remains limited. Therefore,&#xD;
      isokinetic and isometric quadriceps strength of both the operative and non-operative knee&#xD;
      extensors (quadriceps) will be measured post-operatively at approximately 6 months and 9&#xD;
      months post operatively. MRI of bilateral thighs will be performed immediately prior to ACLR&#xD;
      to establish a baseline CSA in the operative and non-operative lower extremity. Then a repeat&#xD;
      MRI will be performed immediately following the conclusion of a standardized 16-week&#xD;
      post-operative rehabilitation regimen among patients randomized to either a standard&#xD;
      rehabilitation regimen (REHAB) or a rehabilitation regimen with BFR (REHAB + BFR.) Finally,&#xD;
      MRI will be repeated at 52 weeks post-operative to examine for latent changes in CSA once&#xD;
      patients have been returned to unrestricted physical activities.&#xD;
&#xD;
      AIM 1: To determine if the addition of BFR therapy to a standard post-operative&#xD;
      rehabilitation protocol increases quadriceps muscle cross sectional area and volume after&#xD;
      ACLR as measured with magnetic resonance imaging (MRI).&#xD;
&#xD;
      Hypothesis: The addition of BFR therapy to a standard post-operative rehabilitation regimen&#xD;
      following ACLR will increase quadriceps muscle CSA and volume when compared to a standard&#xD;
      post-operative rehabilitation regimen measured at 16 weeks post-operative.&#xD;
&#xD;
      AIM 2: To determine if any observed increases in quadriceps muscle CSA and volume are&#xD;
      sustained beyond the cessation of BFR therapy at 16-weeks post-operative by performing repeat&#xD;
      MRI at 52 weeks post-operative&#xD;
&#xD;
      Hypothesis: Observed increases in quadriceps muscle CSA and volume will be sustained beyond&#xD;
      the cessation of BFR therapy at 52 weeks post-operative.&#xD;
&#xD;
      AIM 3: To determine if CSA measurements obtained by MRI reliably predict knee extensor&#xD;
      strength.&#xD;
&#xD;
      Hypothesis: CSA measurements obtained by MRI reliably predict knee extensor strength as&#xD;
      measured by isokinetic and isometric testing.&#xD;
&#xD;
      AIM 4: To determine if the addition of BFR therapy to a standard post-operative&#xD;
      rehabilitation regimen following ACLR results in significantly improved functional outcomes&#xD;
      when compared to a standard post-operative rehabilitation regimen at 24, 36, and 52 weeks&#xD;
      post-operative using patient reported outcomes (PRO).&#xD;
&#xD;
      Hypothesis: The addition of BFR therapy to a standard post-operative rehabilitation regimen&#xD;
      following ACLR will result in significantly improved PRO when compared to a standard&#xD;
      post-operative rehabilitation regimen at 24, 36, and 52-weeks post-operative.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 2021</start_date>
  <completion_date type="Anticipated">August 2022</completion_date>
  <primary_completion_date type="Anticipated">August 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Patients will be randomized to either REHAB or REHAB + BFR (study intervention) using a block randomization scheme.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Investigator)</masking>
    <masking_description>The operating surgeon will remain blinded to the post-operative rehabilitation regimen to which subjects are randomized to post-operative rehabilitation regimen (REHAB vs. REHAB + BFR.)</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Quadriceps CSA MRI</measure>
    <time_frame>7-10 days to 52-54 weeks post-operative</time_frame>
    <description>Quadriceps CSA as measured on MRI</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Knee extensor strength</measure>
    <time_frame>6 to 9 months post-operative</time_frame>
    <description>Knee extensor isokinetic and isometric strength measurements</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Outcome - Pain on 10 cm Visual Analog Scale (VAS)</measure>
    <time_frame>3, 6, and 12 months post-operative clinical follow-up appointments</time_frame>
    <description>The VAS is a unidimensional measure of pain intensity that has been frequently reported among adults. The simplest VAS is represented as a horizontal 10 cm line. The ends are defined as the extreme limits of parameter being measured (e.g. pain) oriented from the left (worst) to the right (best.) Patients are asked mark their perceived level of pain on the horizontal line. The VAS score is determined by measuring in mm from the left hand end of the horizontal line to where the patient marks. A higher score represents greater pain intensity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Outcome - Lyscholms Score</measure>
    <time_frame>3, 6, and 12 months post-operative clinical follow-up appointments</time_frame>
    <description>Comprised of 8 items (limp, support, locking, instability, pain, swelling, stair climbing, squatting), which patients are asked a series of questions to characterize their experiences with respect to each of these 8 items. Patients' responses are summed, with a score of 100 denoting no symptoms or debility.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Outcome - International Knee Documentation Committee Form (IKDC)</measure>
    <time_frame>3, 6, and 12 months post-operative clinical follow-up appointments</time_frame>
    <description>This questionnaire is broken down into three categories: symptoms, sports activity, and knee function. The symptoms subscale focuses on an assessment of pain, stiffness, swelling, and the sensation of &quot;giving-way&quot; of the knee. The sports activity subscale focuses on completion of tasks such as going up and down stairs, rising from a seated position, squatting, and jumping. The knee function subscale asks the respondent to characterize their knee at present versus prior to injury. The IKDC is scored out of 100 points, with a score of 100 representing optimal knee function.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Reported Outcome - Knee Osteoarthritis Outcome Score (KOOS)</measure>
    <time_frame>3, 6, and 12 months post-operative clinical follow-up appointments</time_frame>
    <description>The KOOS is a comprehensive scoring system that evaluates both short and long-term consequence of knee injury. It is comprised of 42 items, which are scored separately in 5 subscales (pain (9 items), other symptoms (7 items), function in daily living (17 items), function in sport and recreation (5 items), and knee-related quality of life (5 items).) Among the strengths of the KOOS as a PRO is its inclusion of two different subscales for physical function relating to daily life, sport, and recreation. A score of 100 represents no knee symptoms, which is then converted to a percentage score to characterize a patient's overall satisfaction with their knee function.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">86</enrollment>
  <condition>ACL Injury</condition>
  <arm_group>
    <arm_group_label>REHAB</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Standard post-operative rehabilitation regimen (REHAB) (Control)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>REHAB + BFR</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Standard rehabilitation regimen with BFR therapy (REHAB + BFR) (Experimental)</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Blood Flow Restriction (BFR) therapy</intervention_name>
    <description>BFR therapy beginning 1-week after ACL reconstruction with quadriceps tendon autograft.</description>
    <arm_group_label>REHAB + BFR</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Standard REHAB</intervention_name>
    <description>Standard post-operative rehabilitation regimen (REHAB) beginning 1-week after ACL reconstruction with quadriceps tendon autograft.</description>
    <arm_group_label>REHAB</arm_group_label>
    <arm_group_label>REHAB + BFR</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Active duty member or Department of Defense Military Health System beneficiary&#xD;
&#xD;
          -  18 to 40 years of age&#xD;
&#xD;
          -  Indicated for ACL reconstruction with quadriceps tendon autograft.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients undergoing a concomitant surgical procedure that would otherwise require a&#xD;
             period of immobilization and/or restricted weight bearing (i.e. meniscal repair,&#xD;
             meniscal allograft transplantation, osteochondral allograft transplantation, high&#xD;
             tibial osteotomy) will be excluded.&#xD;
&#xD;
          -  Undergoing combined multiligamentous knee injury reconstruction&#xD;
&#xD;
          -  Unable to consistently participate in the prescribed post-operative rehabilitation&#xD;
             regimen&#xD;
&#xD;
          -  No patients with a history of recent lower extremity deep vein thrombosis, within the&#xD;
             12 months or on active treatment with anticoagulants, a history of ipsilateral lower&#xD;
             extremity lymph node dissection or a history of endothelial dysfunction.&#xD;
&#xD;
          -  Patients that are unable to obtain MRI secondary to either intolerance and/or&#xD;
             implanted medical devices that preclude the safe completion of the MRI.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Andrew J Sheean, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Brooke Army Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrew J Sheean, MD</last_name>
    <phone>210-916-5425</phone>
    <email>ajsheean@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Daniel J Cognetti, MD</last_name>
    <phone>210-916-5666</phone>
    <email>daniel.j.cognetti.mil@mail.mil</email>
  </overall_contact_backup>
  <reference>
    <citation>Sanders TL, Maradit Kremers H, Bryan AJ, Larson DR, Dahm DL, Levy BA, Stuart MJ, Krych AJ. Incidence of Anterior Cruciate Ligament Tears and Reconstruction: A 21-Year Population-Based Study. Am J Sports Med. 2016 Jun;44(6):1502-7. doi: 10.1177/0363546516629944. Epub 2016 Feb 26.</citation>
    <PMID>26920430</PMID>
  </reference>
  <reference>
    <citation>Goetschius J, Hart JM. Knee-Extension Torque Variability and Subjective Knee Function in Patients with a History of Anterior Cruciate Ligament Reconstruction. J Athl Train. 2016 Jan;51(1):22-7. doi: 10.4085/1062-6050-51.1.12. Epub 2015 Dec 31.</citation>
    <PMID>26720104</PMID>
  </reference>
  <reference>
    <citation>Zwolski C, Schmitt LC, Quatman-Yates C, Thomas S, Hewett TE, Paterno MV. The influence of quadriceps strength asymmetry on patient-reported function at time of return to sport after anterior cruciate ligament reconstruction. Am J Sports Med. 2015 Sep;43(9):2242-9. doi: 10.1177/0363546515591258. Epub 2015 Jul 16.</citation>
    <PMID>26183172</PMID>
  </reference>
  <reference>
    <citation>Thomas AC, Wojtys EM, Brandon C, Palmieri-Smith RM. Muscle atrophy contributes to quadriceps weakness after anterior cruciate ligament reconstruction. J Sci Med Sport. 2016 Jan;19(1):7-11. doi: 10.1016/j.jsams.2014.12.009. Epub 2015 Jan 13.</citation>
    <PMID>25683732</PMID>
  </reference>
  <reference>
    <citation>Kuenze C, Hertel J, Saliba S, Diduch DR, Weltman A, Hart JM. Clinical thresholds for quadriceps assessment after anterior cruciate ligament reconstruction. J Sport Rehabil. 2015 Feb;24(1):36-46. doi: 10.1123/jsr.2013-0110. Epub 2014 Sep 8.</citation>
    <PMID>25203517</PMID>
  </reference>
  <reference>
    <citation>Johnston PT, McClelland JA, Webster KE. Lower Limb Biomechanics During Single-Leg Landings Following Anterior Cruciate Ligament Reconstruction: A Systematic Review and Meta-Analysis. Sports Med. 2018 Sep;48(9):2103-2126. doi: 10.1007/s40279-018-0942-0. Review.</citation>
    <PMID>29949109</PMID>
  </reference>
  <reference>
    <citation>Garber CE, Blissmer B, Deschenes MR, Franklin BA, Lamonte MJ, Lee IM, Nieman DC, Swain DP; American College of Sports Medicine. American College of Sports Medicine position stand. Quantity and quality of exercise for developing and maintaining cardiorespiratory, musculoskeletal, and neuromotor fitness in apparently healthy adults: guidance for prescribing exercise. Med Sci Sports Exerc. 2011 Jul;43(7):1334-59. doi: 10.1249/MSS.0b013e318213fefb.</citation>
    <PMID>21694556</PMID>
  </reference>
  <reference>
    <citation>Burgomaster KA, Moore DR, Schofield LM, Phillips SM, Sale DG, Gibala MJ. Resistance training with vascular occlusion: metabolic adaptations in human muscle. Med Sci Sports Exerc. 2003 Jul;35(7):1203-8.</citation>
    <PMID>12840643</PMID>
  </reference>
  <reference>
    <citation>Takarada Y, Tsuruta T, Ishii N. Cooperative effects of exercise and occlusive stimuli on muscular function in low-intensity resistance exercise with moderate vascular occlusion. Jpn J Physiol. 2004 Dec;54(6):585-92.</citation>
    <PMID>15760491</PMID>
  </reference>
  <reference>
    <citation>Loenneke JP, Kim D, Fahs CA, Thiebaud RS, Abe T, Larson RD, Bemben DA, Bemben MG. Effects of exercise with and without different degrees of blood flow restriction on torque and muscle activation. Muscle Nerve. 2015 May;51(5):713-21. doi: 10.1002/mus.24448.</citation>
    <PMID>25187395</PMID>
  </reference>
  <reference>
    <citation>Hughes L, Paton B, Rosenblatt B, Gissane C, Patterson SD. Blood flow restriction training in clinical musculoskeletal rehabilitation: a systematic review and meta-analysis. Br J Sports Med. 2017 Jul;51(13):1003-1011. doi: 10.1136/bjsports-2016-097071. Epub 2017 Mar 4. Review.</citation>
    <PMID>28259850</PMID>
  </reference>
  <reference>
    <citation>Loenneke JP, Wilson JM, Wilson GJ, Pujol TJ, Bemben MG. Potential safety issues with blood flow restriction training. Scand J Med Sci Sports. 2011 Aug;21(4):510-8. doi: 10.1111/j.1600-0838.2010.01290.x. Epub 2011 Mar 16. Review.</citation>
    <PMID>21410544</PMID>
  </reference>
  <reference>
    <citation>DePhillipo NN, Kennedy MI, Aman ZS, Bernhardson AS, O'Brien L, LaPrade RF. Blood Flow Restriction Therapy After Knee Surgery: Indications, Safety Considerations, and Postoperative Protocol. Arthrosc Tech. 2018 Sep 24;7(10):e1037-e1043. doi: 10.1016/j.eats.2018.06.010. eCollection 2018 Oct.</citation>
    <PMID>30377584</PMID>
  </reference>
  <reference>
    <citation>Tennent DJ, Hylden CM, Johnson AE, Burns TC, Wilken JM, Owens JG. Blood Flow Restriction Training After Knee Arthroscopy: A Randomized Controlled Pilot Study. Clin J Sport Med. 2017 May;27(3):245-252. doi: 10.1097/JSM.0000000000000377.</citation>
    <PMID>27749358</PMID>
  </reference>
  <reference>
    <citation>Iversen E, RÃ¸stad V, Larmo A. Intermittent blood flow restriction does not reduce atrophy following anterior cruciate ligament reconstruction. J Sport Health Sci. 2016 Mar;5(1):115-118. doi: 10.1016/j.jshs.2014.12.005. Epub 2015 Apr 18.</citation>
    <PMID>30356481</PMID>
  </reference>
  <reference>
    <citation>Takarada Y, Takazawa H, Ishii N. Applications of vascular occlusion diminish disuse atrophy of knee extensor muscles. Med Sci Sports Exerc. 2000 Dec;32(12):2035-9.</citation>
    <PMID>11128848</PMID>
  </reference>
  <reference>
    <citation>Kuenze CM, Blemker SS, Hart JM. Quadriceps function relates to muscle size following ACL reconstruction. J Orthop Res. 2016 Sep;34(9):1656-62. doi: 10.1002/jor.23166. Epub 2016 Jan 27.</citation>
    <PMID>26763833</PMID>
  </reference>
  <reference>
    <citation>Sheean AJ, Musahl V, Slone HS, Xerogeanes JW, Milinkovic D, Fink C, Hoser C; International Quadriceps Tendon Interest Group. Quadriceps tendon autograft for arthroscopic knee ligament reconstruction: use it now, use it often. Br J Sports Med. 2018 Jun;52(11):698-701. doi: 10.1136/bjsports-2017-098769. Epub 2018 Apr 28. Review.</citation>
    <PMID>29705749</PMID>
  </reference>
  <reference>
    <citation>Samuelsen BT, Webster KE, Johnson NR, Hewett TE, Krych AJ. Hamstring Autograft versus Patellar Tendon Autograft for ACL Reconstruction: Is There a Difference in Graft Failure Rate? A Meta-analysis of 47,613 Patients. Clin Orthop Relat Res. 2017 Oct;475(10):2459-2468. doi: 10.1007/s11999-017-5278-9.</citation>
    <PMID>28205075</PMID>
  </reference>
  <reference>
    <citation>Myles PS, Myles DB, Galagher W, Boyd D, Chew C, MacDonald N, Dennis A. Measuring acute postoperative pain using the visual analog scale: the minimal clinically important difference and patient acceptable symptom state. Br J Anaesth. 2017 Mar 1;118(3):424-429. doi: 10.1093/bja/aew466.</citation>
    <PMID>28186223</PMID>
  </reference>
  <reference>
    <citation>Briggs KK, Steadman JR, Hay CJ, Hines SL. Lysholm score and Tegner activity level in individuals with normal knees. Am J Sports Med. 2009 May;37(5):898-901. doi: 10.1177/0363546508330149. Epub 2009 Mar 23.</citation>
    <PMID>19307332</PMID>
  </reference>
  <reference>
    <citation>Ra HJ, Kim HS, Choi JY, Ha JK, Kim JY, Kim JG. Comparison of the ceiling effect in the Lysholm score and the IKDC subjective score for assessing functional outcome after ACL reconstruction. Knee. 2014 Oct;21(5):906-10. doi: 10.1016/j.knee.2014.06.004. Epub 2014 Jun 21.</citation>
    <PMID>24998912</PMID>
  </reference>
  <reference>
    <citation>Grevnerts HT, Terwee CB, Kvist J. The measurement properties of the IKDC-subjective knee form. Knee Surg Sports Traumatol Arthrosc. 2015 Dec;23(12):3698-706. doi: 10.1007/s00167-014-3283-z. Epub 2014 Sep 6. Review.</citation>
    <PMID>25193574</PMID>
  </reference>
  <reference>
    <citation>Gerber JP, Marcus RL, Dibble LE, Greis PE, Burks RT, LaStayo PC. Effects of early progressive eccentric exercise on muscle structure after anterior cruciate ligament reconstruction. J Bone Joint Surg Am. 2007 Mar;89(3):559-70.</citation>
    <PMID>17332105</PMID>
  </reference>
  <reference>
    <citation>Agarwalla A, Puzzitiello RN, Liu JN, Cvetanovich GL, Gowd AK, Verma NN, Cole BJ, Forsythe B. Timeline for Maximal Subjective Outcome Improvement After Anterior Cruciate Ligament Reconstruction. Am J Sports Med. 2019 Aug;47(10):2501-2509. doi: 10.1177/0363546518803365. Epub 2018 Nov 12.</citation>
    <PMID>30419175</PMID>
  </reference>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>August 14, 2020</study_first_submitted>
  <study_first_submitted_qc>August 19, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">August 20, 2020</study_first_posted>
  <last_update_submitted>February 1, 2021</last_update_submitted>
  <last_update_submitted_qc>February 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Brooke Army Medical Center</investigator_affiliation>
    <investigator_full_name>Dr. Andrew Sheean</investigator_full_name>
    <investigator_title>Director of Resident Research, Orthopaedic Sports Medicine, Principal Investigator, Staff Orthopaedic Surgeon</investigator_title>
  </responsible_party>
  <keyword>BFR</keyword>
  <keyword>ACLR</keyword>
  <keyword>Quadriceps Tendon</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Anterior Cruciate Ligament Injuries</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

